| CAS No. | 656247-18-6 |
|---|---|
| MDL No. | MFCD26142360 |
| MF | C33H39N5O7S |
| MW | 649.80 |
| InChI Key | ZNMRDZZRAFJOKY-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Nintedanib esylate is an organosulfonate salt formed by combining nintedanib with one molar equivalent of ethanesulfonic acid. It is a kinase inhibitor used in the treatment of idiopathic pulmonary fibrosis and cancer. It functions as an angiogenesis inhibitor, antineoplastic agent, fibroblast growth factor receptor antagonist, tyrosine kinase inhibitor, and vascular endothelial growth factor receptor antagonist. It contains a nintedanib(1+) moiety.
| CAS No. | 656247-18-6 |
|---|---|
| Product Name | Nintedanib esylate |
